Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nam H Dang

Showing results (51-60 of 121) with videos related to

Pageof 13
Sort By:
Biochemical and Biophysical Research Communications|April 22, 2014
CD26-mediated regulation of periostin expression contributes to migration and invasion of malignant pleural mesothelioma cellsEriko Komiya, Kei Ohnuma, Hiroto Yamazaki, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 31, 2014
CD26-mediated induction of EGR2 and IL-10 as potential regulatory mechanism for CD26 costimulatory pathwayRyo Hatano, Kei Ohnuma, Haruna Otsuka, et al.
Biochemical and Biophysical Research Communications|March 4, 2009
CD9 correlates with cancer stem cell potentials in human B-acute lymphoblastic leukemia cellsHiroko Nishida, Hiroto Yamazaki, Taketo Yamada, et al.
Clinical & Developmental Immunology|September 26, 2008
Comparative study of regulatory T cell function of human CD25CD4 T cells from thymocytes, cord blood, and adult peripheral bloodWakae Fujimaki, Nozomu Takahashi, Kei Ohnuma, et al.
Biochemical and Biophysical Research Communications|September 11, 2018
Targeting CD26 suppresses proliferation of malignant mesothelioma cell via downmodulation of ubiquitin-specific protease 22Toshihiro Okamoto, Hiroto Yamazaki, Ryo Hatano, et al.
Cancer Research|March 9, 2005
Regulation of p38 phosphorylation and topoisomerase IIalpha expression in the B-cell lymphoma line Jiyoye by CD26/dipeptidyl peptidase IV is associated with enhanced in vitro and in vivo sensitivity to doxorubicinToshiko Yamochi, Tadanori Yamochi, Ugur Aytac, et al.
Cancer Medicine|May 25, 2019
Dipeptidyl peptidase 4 inhibitors as novel agents in improving survival in diabetic patients with colorectal cancer and lung cancer: A Surveillance Epidemiology and Endpoint Research Medicare studyRohit Bishnoi, Young-Rock Hong, Chintan Shah, et al.
Stroke|October 8, 2005
Nedd9 protein, a Cas-L homologue, is upregulated after transient global ischemia in rats: possible involvement of Nedd9 in the differentiation of neurons after ischemiaTakahiro Sasaki, Satoshi Iwata, Hirotaka James Okano, et al.
Frontiers in Oncology|April 17, 2020
Impact of DPP4 Inhibitors in Survival of Patients With Prostate, Pancreas, and Breast CancerChintan Shah, Young-Rock Hong, Rohit Bishnoi, et al.
Biochemical and Biophysical Research Communications|April 8, 2015
The role of Cas-L/NEDD9 as a regulator of collagen-induced arthritis in a murine modelTomoki Katayose, Satoshi Iwata, Naoki Oyaizu, et al.
Pageof 13

Showing results (51-60 of 121) with videos related to

Sort By:
Pageof 13
Biochemical and Biophysical Research Communications|April 22, 2014
CD26-mediated regulation of periostin expression contributes to migration and invasion of malignant pleural mesothelioma cellsEriko Komiya, Kei Ohnuma, Hiroto Yamazaki, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 31, 2014
CD26-mediated induction of EGR2 and IL-10 as potential regulatory mechanism for CD26 costimulatory pathwayRyo Hatano, Kei Ohnuma, Haruna Otsuka, et al.
Biochemical and Biophysical Research Communications|March 4, 2009
CD9 correlates with cancer stem cell potentials in human B-acute lymphoblastic leukemia cellsHiroko Nishida, Hiroto Yamazaki, Taketo Yamada, et al.
Clinical & Developmental Immunology|September 26, 2008
Comparative study of regulatory T cell function of human CD25CD4 T cells from thymocytes, cord blood, and adult peripheral bloodWakae Fujimaki, Nozomu Takahashi, Kei Ohnuma, et al.
Biochemical and Biophysical Research Communications|September 11, 2018
Targeting CD26 suppresses proliferation of malignant mesothelioma cell via downmodulation of ubiquitin-specific protease 22Toshihiro Okamoto, Hiroto Yamazaki, Ryo Hatano, et al.
Cancer Research|March 9, 2005
Regulation of p38 phosphorylation and topoisomerase IIalpha expression in the B-cell lymphoma line Jiyoye by CD26/dipeptidyl peptidase IV is associated with enhanced in vitro and in vivo sensitivity to doxorubicinToshiko Yamochi, Tadanori Yamochi, Ugur Aytac, et al.
Cancer Medicine|May 25, 2019
Dipeptidyl peptidase 4 inhibitors as novel agents in improving survival in diabetic patients with colorectal cancer and lung cancer: A Surveillance Epidemiology and Endpoint Research Medicare studyRohit Bishnoi, Young-Rock Hong, Chintan Shah, et al.
Stroke|October 8, 2005
Nedd9 protein, a Cas-L homologue, is upregulated after transient global ischemia in rats: possible involvement of Nedd9 in the differentiation of neurons after ischemiaTakahiro Sasaki, Satoshi Iwata, Hirotaka James Okano, et al.
Frontiers in Oncology|April 17, 2020
Impact of DPP4 Inhibitors in Survival of Patients With Prostate, Pancreas, and Breast CancerChintan Shah, Young-Rock Hong, Rohit Bishnoi, et al.
Biochemical and Biophysical Research Communications|April 8, 2015
The role of Cas-L/NEDD9 as a regulator of collagen-induced arthritis in a murine modelTomoki Katayose, Satoshi Iwata, Naoki Oyaizu, et al.
Pageof 13